SULFONAMIDE-REACTIVE LYMPHOCYTES DETECTED AT VERY-LOW FREQUENCY IN THE PERIPHERAL-BLOOD OF PATIENTS WITH DRUG-INDUCED ERUPTIONS

被引:47
作者
KALISH, RS
LAPORTE, A
WOOD, JA
JOHNSON, KL
机构
[1] Department of Dermatology, State University of New York at Stony Brook, Stony Brook, NY
关键词
DRUG ERUPTION; DRUG HYPERSENSITIVITY; LYMPHOCYTE; INTERLEUKIN-2; SULFAMETHOXAZOLE; FUROSEMIDE; LYMPHOCYTE TRANSFORMATION TEST;
D O I
10.1016/0091-6749(94)90202-X
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: The role of T lymphocytes in mediating drug eruptions is uncertain. Methods: Twenty-four patients with eruptions induced by sulfonamide-related drugs were studied to detect lymphocyte reactivity to drugs. Both the lymphocyte transformation test and limiting dilution analysis were used as assays for drug-reactive lymphocytes. Peripheral blood lymphocytes were expanded in interleukin-2 and tested for reactivity to sulfamethoxazole and furosemide. Results: The lymphocyte transformation test results to sulfamethoxazole, sulfisoxazole, and furosemide were found to be generally unreliable with a high rate of false-negative and false-positive results. However, as determined by limiting dilution analysis, sulfamethoxazole-reactive lymphocytes were detected in the peripheral blood of one patient at a frequency of 1/172,000. This is within the lower range of frequencies of urushiol-reactive T cells in the peripheral blood of patients with allergic contact dermatitis to urushiol (poison ivy). Two sulfonamide-reactive lymphocyte lines were cultured from two patients. Both lines proliferated in response to sulfamethoxazole but not in response to furosemide, suggesting that furosemide does not cross-react with the sulfonamides. Conclusions: Lymphocytes reactive to sulfamethoxazole were detected at low frequencies in the peripheral blood of three patients with drug eruptions secondary to administration of sulfamethoxazole.
引用
收藏
页码:465 / 472
页数:8
相关论文
共 34 条
[1]  
ASSEM ESK, 1974, IMMUNOLOGY, V27, P255
[2]  
BIGBY M, 1986, Journal of the American Medical Association, V256, P3358, DOI 10.1001/jama.256.24.3358
[3]  
BOECKER C, 1993, J INVEST DERMATOL, V100, P540
[4]  
CRIBB AE, 1990, MOL PHARMACOL, V38, P744
[5]  
CRIBB AE, 1991, DRUG METAB DISPOS, V19, P900
[6]  
CRIBB AE, 1991, J PHARMACOL EXP THER, V259, P1241
[7]   SULFAMETHOXAZOLE IS METABOLIZED TO THE HYDROXYLAMINE IN HUMANS [J].
CRIBB, AE ;
SPIELBERG, SP .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (05) :522-526
[8]   LYMPHOCYTE-TRANSFORMATION TEST IN DETECTION OF DRUG HYPERSENSITIVITY [J].
DOBOZY, A ;
HUNYADI, J ;
SZKENDERESSY, A ;
SIMON, N .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1981, 6 (04) :367-372
[9]  
DVORAK HF, 1977, J IMMUNOL, V118, P1549
[10]   LYMPHOCYTE-TRANSFORMATION TEST IN FIXED DRUG ERUPTION [J].
GIMENEZCAMARASA, JM ;
GARCIACALDERON, P ;
MORAGAS, JMD .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (16) :819-821